LRRK2 Gene PARK8 Parkinson Genetic Test
At DNA Labs UAE, we offer the LRRK2 Gene PARK8 Parkinson Genetic Test to assess the risk of developing Parkinson’s disease. This test is designed to analyze the LRRK2 gene, specifically in the PARK8 locus, which has been identified as a cause of familial Parkinson’s disease.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
After the test is conducted, the report will be delivered within 3 to 4 weeks.
Method
The LRRK2 Gene PARK8 Parkinson Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This method allows for the simultaneous analysis of multiple genes for mutations or variations.
Test Type
The LRRK2 Gene PARK8 Parkinson Genetic Test falls under the category of Neurological Disorders.
Doctor
The test is conducted under the supervision of a Neurologist.
Test Department
The LRRK2 Gene PARK8 Parkinson Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the LRRK2 Gene PARK8 Parkinson NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by LRRK2 Gene PARK8 Parkinson.
Test Details
The LRRK2 gene is associated with an increased risk of developing Parkinson’s disease. Mutations in this gene, specifically in the PARK8 locus, have been identified as a cause of familial Parkinson’s disease.
NGS genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations. In the context of Parkinson’s disease, NGS genetic testing can be used to identify mutations in the LRRK2 gene that may contribute to the development of the disease.
By analyzing the LRRK2 gene through NGS genetic testing, healthcare professionals can provide individuals with information about their genetic risk for Parkinson’s disease. This information can be useful for early detection, prevention, and personalized treatment plans.
It is important to note that not all individuals with LRRK2 mutations will develop Parkinson’s disease, as other factors, both genetic and environmental, can influence the disease’s onset and progression.
Test Name | LRRK2 Gene PARK8 Parkinson Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for LRRK2 Gene PARK8 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LRRK2 Gene PARK8 Parkinson |
Test Details |
The LRRK2 gene is associated with an increased risk of developing Parkinson’s disease. Mutations in this gene, specifically in the PARK8 locus, have been identified as a cause of familial Parkinson’s disease. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations. In the context of Parkinson’s disease, NGS genetic testing can be used to identify mutations in the LRRK2 gene that may contribute to the development of the disease. By analyzing the LRRK2 gene through NGS genetic testing, healthcare professionals can provide individuals with information about their genetic risk for Parkinson’s disease. This information can be useful for early detection, prevention, and personalized treatment plans. It is important to note that not all individuals with LRRK2 mutations will develop Parkinson’s disease, as other factors, both genetic and environmental, can influence the disease’s onset and progression. |